CheckMyRecalls

Lupin Pharmaceuticals Inc. recalls Levothyroxine Sodium Tablets

Published
8 Jan 2025
Units affected
480 1000-count bottles
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited, Pithampur (M.P)- 454 775 INDIA, NDC# 68180-967-03

Brand / company
Lupin Pharmaceuticals Inc.
Codes / lots
Lot# LA01276, Exp Date: 07/2026
Distribution
One US distributor in Ohio.
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 8 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.